These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4823906)

  • 1. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
    Medoff G; Valeriote F; Lynch RG; Schlessinger D; Kobayashi GS
    Cancer Res; 1974 May; 34(5):974-8. PubMed ID: 4823906
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Valeriote F; Lynch R; Medoff G; Tolen S; Dieckman J
    J Natl Cancer Inst; 1978 Aug; 61(2):399-402. PubMed ID: 277727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency.
    Medoff G; Valeriote F; Ryan J; Tolen S
    J Natl Cancer Inst; 1977 Apr; 58(4):949-53. PubMed ID: 845998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A murine model for central nervous system leukemia and its possible relevance to human leukemia.
    Lynch RG; Medoff G; Valeriote F
    J Natl Cancer Inst; 1975 Sep; 55(3):611-7. PubMed ID: 1159838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of anticancer agents by amphotericin B.
    Medoff G; Valeriote F; Dieckman J
    J Natl Cancer Inst; 1981 Jul; 67(1):131-5. PubMed ID: 6942183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1.
    Valeriote F; Medoff G; Dieckman J
    Cancer Res; 1979 Jun; 39(6 Pt 1):2041-5. PubMed ID: 445402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
    Valeriote F; Dieckman J; Chabot G
    J Natl Cancer Inst; 1986 Mar; 76(3):521-5. PubMed ID: 3456466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antileukemic effect of theophylline and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    DeWys WD; Bathina SH
    Cancer Res; 1980 Jul; 40(7):2202-8. PubMed ID: 6248198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief communication: polyene potentiation of antitumor agents.
    Medoff G; Schlessinger D; Kobayashi GS
    J Natl Cancer Inst; 1973 Apr; 50(4):1047-50. PubMed ID: 4703768
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary observations on the effect of glucan in combination with radiation and chemotherapy in four murine tumors.
    Stewart CC; Valeriote FA; Perez CA
    Cancer Treat Rep; 1978 Nov; 62(11):1867-72. PubMed ID: 728904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of cytotoxicity of anticancer agents by several different polyene antibiotics.
    Valeriote F; Medoff G; Dieckman J
    J Natl Cancer Inst; 1984 Feb; 72(2):435-9. PubMed ID: 6582328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1980 Jan; 64(1):69-72. PubMed ID: 6928048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 17. 1,3 Bis (2-chloroethyl)-1-nitrosourea-induced host resistance to syngeneic LSA mouse leukemia.
    Maruyama Y; Feola J
    Leuk Res; 1980; 4(5):427-35. PubMed ID: 7230867
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo sister chromatid exchange and cellular replication kinetics of normal and lymphoma AKR bone marrow cells.
    Biegel JA; Boggs SS; Conner MK
    Cancer Res; 1982 Jul; 42(7):2813-5. PubMed ID: 7083171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).
    Roberts D; Peck C; Hilliard S; Karas JG
    Cancer Res; 1981 Oct; 41(10):3891-5. PubMed ID: 7284998
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
    Valeriote F; Tolen S
    Cancer Res; 1982 Nov; 42(11):4330-1. PubMed ID: 6290032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.